ImmunityBio, Inc. (NASDAQ:IBRX – Get Rating)’s share price dropped 5.9% on Tuesday . The company traded as low as $2.95 and last traded at $3.03. Approximately 1,708,953 shares changed hands during trading, a decline of 62% from the average daily volume of 4,503,949 shares. The stock had previously closed at $3.22. Analyst Ratings Changes Separately, […]
Piper Sandler downgraded shares of ImmunityBio (NASDAQ:IBRX – Get Rating) from an overweight rating to a neutral rating in a research note released on Friday morning, The Fly reports. The brokerage currently has $4.00 target price on the stock, down from their prior target price of $10.00. ImmunityBio Price Performance ImmunityBio stock opened at $2.28 […]
ImmunityBio, Inc. (NASDAQ:IBRX – Get Rating)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $2.79, but opened at $2.88. ImmunityBio shares last traded at $2.52, with a volume of 1,681,169 shares traded. Analyst Ratings Changes Separately, Piper Sandler cut ImmunityBio from an “overweight” rating to a […]
ImmunityBio, Inc. (NASDAQ:IBRX – Get Rating)’s stock price traded up 8.8% during trading on Wednesday . The company traded as high as $3.36 and last traded at $3.35. 1,862,162 shares were traded during trading, a decline of 49% from the average session volume of 3,619,296 shares. The stock had previously closed at $3.08. ImmunityBio Trading […]
Shares of ImmunityBio, Inc. (NASDAQ:IBRX – Get Rating) shot up 8.8% during trading on Wednesday . The company traded as high as $3.36 and last traded at $3.35. 1,862,162 shares traded hands during mid-day trading, a decline of 49% from the average session volume of 3,619,296 shares. The stock had previously closed at $3.08. ImmunityBio […]